The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS
- 28 October 2015
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 32 (2) , 143-146
Abstract
We investigated the association between the amount and duration of smoking on biochemical, clinical parameters and the ovarian morphology in women with polycystic ovary syndrome (PCOS). That was a retrospective study. These women were divided into two groups, non-smokers (217) and smokers (92). The amount of cigarettes and duration of smoking was measured in pack-years. Both groups underwent clinical evaluation, biochemical and hormone analysis, transvaginal ultrasound and oral glucose tolerance tests (OGTT). The mean value of the number of cigarettes was 14.8 (±8.8) and the median value of pack-years in the smokers group was 4.0 (1.5–7.5). Smokers group has significantly higher free testosterone (F-T), 17-hydroxyprogesterone (17-OHP), delta 4 androstenedione (Δ4-A), T4, low-density lipoprotein (LDL), and white blood cells (WBC). During correlation of all the above parameters and pack-years, there has been significant positive correlation in F-T and Δ4-A. The participants with more pack-years showed statistically higher values of F-T and Δ4-A. There was also a significant positive correlation between total cholesterol, triglycerides, WBC and pack-years of the participants. Prolactin (PRL) has been inversely associated with pack-years. We concluded that the increase of pack-years aggravated lipid profile, WBC and decreased PRL levels, in PCOS patients.Keywords
This publication has 24 references indexed in Scilit:
- Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndromeGynecological Endocrinology, 2011
- Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistanceFertility and Sterility, 2010
- Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitionsGynecological Endocrinology, 2009
- Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing EnzymesJournal of Neurogenetics, 2009
- Smoking and smoking cessation—The relationship between cardiovascular disease and lipoprotein metabolism: A reviewAtherosclerosis, 2008
- Hirsutism and acne in polycystic ovary syndromeBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Is calculating pack‐years retrospectively a valid method to estimate life‐time tobacco smoking? A comparison between prospectively calculated pack‐years and retrospectively calculated pack‐yearsAddiction, 2001
- Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In HumansThe Journal of Clinical Endocrinology & Metabolism, 2000
- Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.BMJ, 1989